These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management of recurrent aphthous ulcers. A trial of carbenoxolone sodium mouthwash. Poswillo D; Partridge M Br Dent J; 1984 Jul; 157(2):55-7. PubMed ID: 6588992 [No Abstract] [Full Text] [Related]
6. [Carbenoxolone in the treatment of duodenal ulcer]. Kadish U; Neeman A Harefuah; 1979 Sep; 97(5-6):111-2. PubMed ID: 540839 [No Abstract] [Full Text] [Related]
7. [Use of a metoclopramide-carbenoxolone combination in duodenal reflux pathology]. Procacciante F; Pronio A; Perri S; Catani M; Montesani C; Citone G; Ribotta G Minerva Chir; 1987 Oct; 42(19):1487-90. PubMed ID: 3683907 [No Abstract] [Full Text] [Related]
8. Duodenal mycosis during carbenoxolone and cimetidine treatment. Lombardo L; Pera A; Genovesio L; Verme G Lancet; 1979 Mar; 1(8116):607-8. PubMed ID: 85187 [No Abstract] [Full Text] [Related]
9. Importance of defensive factors in the prevention of peptic ulcer recurrence. Role of carbenoxolone sodium. Guslandi M Acta Gastroenterol Belg; 1983; 46(9-10):411-8. PubMed ID: 6673456 [No Abstract] [Full Text] [Related]
10. Prevention of stress ulcerations with cimetidine and carbenoxolone. Strauss RJ; Stein T; Mandell C; Wise L Surg Forum; 1977; 28():361-3. PubMed ID: 617465 [No Abstract] [Full Text] [Related]
11. [Comparative study of placebo, atropine, cimetidine and carbenoxolone in patients with duodenal ulcer]. Tárnok F; Jávor T; Mózsik G; Nagy L; Patty I; Rumi G; Solt I Orv Hetil; 1980 Jun; 121(26):1567-70. PubMed ID: 7454266 [No Abstract] [Full Text] [Related]
12. Carbenoxolone maintenance in cimetidine-healed patients. Guslandi M; Cambielli M; Tittobello A Scand J Gastroenterol; 1980; 15(3):369-71. PubMed ID: 7433897 [TBL] [Abstract][Full Text] [Related]
13. XI international congress of gastroenterology. Hamburg, FRG, Carbenoxolone symposium, June 1980. Scand J Gastroenterol Suppl; 1980; 65():1-121. PubMed ID: 6111118 [No Abstract] [Full Text] [Related]
14. Comparative study of carbenoxolone and cimetidine in the management of duodenal ulcer. Reed PI; Vincent-Brown A; Cook PJ; Colaco CB; Perks S; Baron JH; Jewell DP Acta Gastroenterol Belg; 1983; 46(9-10):459-68. PubMed ID: 6673457 [No Abstract] [Full Text] [Related]
15. Serum carbenoxolone: ulcer-healing and metabolic effects. Wright PA; Reed PI; Davies WA; St John DJ; Young GP; House FR; Gribble RJ; Baron JH Scand J Gastroenterol Suppl; 1980; 65():41-8. PubMed ID: 6937940 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of cimetidine-resistant gastric ulcer with carbenoxolone-sodium (author's transl)]. Simon B; Kather H; Kommerell B Med Klin; 1979 Aug; 74(35):1250-3. PubMed ID: 492046 [TBL] [Abstract][Full Text] [Related]
17. The effect of carbenoxolone on the chronic atrophic gastric mucosa determined by flow cytometry and histoautoradiography. Weiss H; Steenbeck L; Gütz HJ; Wolff G Digestion; 1981; 21(3):151-5. PubMed ID: 7215718 [TBL] [Abstract][Full Text] [Related]
19. Histochemistry of the gastric and duodenal mucosa under cimetidine and carbenoxolone treatment. Lojda Z; Maratka Z Scand J Gastroenterol Suppl; 1989; 167():13-5. PubMed ID: 2617161 [TBL] [Abstract][Full Text] [Related]
20. [Therapy of peptic ulcer with cytoprotective substances]. Fortunat W Wien Med Wochenschr; 1983; 133(4-5):94-8. PubMed ID: 6407215 [No Abstract] [Full Text] [Related] [Next] [New Search]